Human KDM5A/RBBP-2/RBBP2 ORF/cDNA clone-Adenovirus particle (NM_001042603)

Cat. No.: vGMAD000038

Pre-made Human KDM5A/RBBP-2/RBBP2 Adenovirus for KDM5A overexpression in-vitro and in-vivo. The KDM5A adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified KDM5A-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to RBP2/KDM5A/KDM5A/RBBP-2 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAD000038 Human KDM5A Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAD000038
Gene Name KDM5A
Accession Number NM_001042603
Gene ID 5927
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 5073 bp
Gene Alias RBBP-2,RBBP2,RBP2
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag Null
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCGGGCGTGGGGCCGGGGGGCTACGCGGCGGAGTTCGTGCCACCGCCAGAGTGCCCCGTCTTTGAGCCGAGTTGGGAGGAGTTCACAGATCCGCTCAGCTTTATCGGCCGCATCCGGCCTTTGGCGGAGAAAACCGGCATCTGCAAAATTCGGCCGCCCAAGGACTGGCAGCCTCCATTTGCCTGTGAAGTAAAAAGCTTTCGTTTCACTCCAAGAGTCCAGCGCCTGAATGAACTTGAGGCAATGACCAGAGTGAGATTGGATTTCTTGGATCAACTAGCAAAATTTTGGGAACTTCAAGGATCTACTCTGAAGATCCCTGTGGTAGAGAGAAAAATCCTGGATCTGTATGCTTTGAGCAAGATTGTTGCCAGCAAAGGAGGTTTTGAAATGGTCACCAAAGAGAAGAAATGGTCTAAAGTGGGTAGTCGCTTGGGATATCTGCCAGGAAAAGGAACTGGGTCTCTTTTGAAGTCACATTATGAAAGAATTCTCTACCCATATGAGCTTTTCCAGTCTGGTGTGAGCCTTATGGGTGTGCAGATGCCTAATTTAGATCTTAAAGAAAAAGTGGAGCCTGAGGTTCTCAGCACTGATACCCAAACTTCCCCAGAGCCAGGCACAAGGATGAACATTCTGCCGAAGAGAACAAGACGTGTGAAGACTCAGTCAGAATCTGGAGATGTGAGTAGAAACACGGAACTGAAGAAACTTCAGATTTTTGGGGCTGGGCCCAAGGTTGTGGGCTTGGCAATGGGAACAAAAGATAAAGAAGATGAGGTCACCCGAAGACGAAAAGTTACCAACAGGTCAGACGCATTTAACATGCAAATGAGACAACGGAAAGGCACTCTCTCTGTTAACTTTGTTGATCTCTATGTTTGTATGTTTTGTGGTCGGGGAAACAATGAAGATAAATTGCTTTTGTGTGATGGATGTGATGACAGCTATCATACATTTTGTCTAATTCCTCCACTACCTGATGTGCCCAAAGGAGACTGGAGGTGTCCTAAATGTGTCGCCGAGGAATGTAGCAAACCTCGAGAAGCCTTTGGATTTGAACAAGCTGTACGAGAGTATACACTTCAGAGCTTTGGAGAGATGGCAGATAATTTTAAGTCTGATTATTTTAATATGCCAGTCCATATGGTTCCCACAGAACTAGTAGAAAAGGAATTTTGGCGGCTGGTAAGCAGCATTGAAGAAGATGTTATTGTGGAATATGGAGCAGATATCTCCTCAAAAGACTTTGGAAGTGGATTTCCGGTGAAGGATGGGCGGAGAAAGATTCTGCCAGAAGAAGAGGAATATGCACTTTCTGGTTGGAATTTGAATAACATGCCTGTCCTGGAACAGTCTGTTCTTGCACATATTAATGTGGACATCTCTGGTATGAAAGTGCCGTGGCTCTATGTGGGAATGTGCTTCTCTTCTTTTTGCTGGCACATTGAGGATCACTGGAGTTATTCCATCAACTACTTGCACTGGGGGGAGCCAAAGACATGGTATGGTGTGCCATCTCATGCTGCAGAGCAACTGGAGGAGGTGATGAGAGAGCTGGCCCCCGAGTTATTTGAATCCCAGCCTGATCTTCTGCATCAGTTAGTTACCATCATGAACCCCAACGTGCTAATGGAGCATGGTGTGCCTGTGTACAGGACCAATCAGTGTGCTGGCGAGTTTGTTGTGACATTTCCTCGTGCCTATCACTCTGGATTTAACCAGGGCTACAACTTTGCTGAAGCTGTGAACTTCTGTACTGCTGACTGGTTGCCCATTGGACGTCAATGTGTAAATCATTACCGACGCCTAAGGCGCCACTGTGTCTTTTCACACGAGGAACTAATTTTCAAGATGGCAGCAGATCCAGAATGCTTAGATGTGGGGCTGGCTGCCATGGTCTGCAAAGAATTGACTCTCATGACTGAAGAAGAAACACGATTAAGAGAGTCTGTTGTACAGATGGGTGTCCTGATGTCAGAAGAAGAAGTGTTTGAACTTGTTCCTGATGATGAGCGGCAGTGTTCAGCATGCAGAACCACATGTTTTCTCTCTGCTCTCACATGTTCCTGTAATCCTGAGCGGCTTGTATGTCTCTACCATCCAACTGATCTGTGCCCCTGCCCCATGCAGAAGAAATGTCTTAGATATCGCTACCCATTAGAAGACCTCCCTTCTCTGCTATATGGTGTAAAAGTCAGGGCACAGTCCTATGACACTTGGGTCAGTCGTGTTACAGAAGCATTGTCTGCTAACTTCAACCACAAAAAAGATTTGATTGAATTGCGAGTAATGCTGGAAGATGCTGAGGATAGGAAATACCCAGAGAATGATCTCTTTCGAAAACTCAGGGATGCTGTAAAAGAAGCTGAGACCTGTGCTTCTGTGGCTCAGCTGCTTCTGAGCAAAAAGCAGAAACACAGACAGAGCCCAGATAGTGGGAGGACTCGGACCAAACTGACAGTGGAAGAATTGAAGGCCTTTGTCCAACAACTTTTTAGTCTTCCGTGTGTCATCAGCCAAGCTCGGCAAGTAAAGAATCTGCTAGATGATGTGGAAGAGTTTCATGAACGTGCTCAGGAGGCCATGATGGATGAAACCCCAGATTCTTCCAAACTCCAGATGTTGATAGATATGGGCTCTAGTCTCTATGTGGAACTCCCTGAATTACCACGACTGAAGCAAGAGCTACAACAGGCTCGGTGGTTGGACGAAGTAAGACTGACCTTATCAGATCCGCAACAAGTCACTTTGGATGTCATGAAGAAGCTGATAGACTCTGGGGTAGGGTTGGCACCCCACCATGCTGTGGAGAAAGCAATGGCTGAACTACAGGAGCTCCTTACAGTCTCTGAACGATGGGAAGAAAAGGCTAAGGTCTGCCTACAGGCAAGACCGAGGCACAGTGTGGCAAGTTTAGAAAGCATTGTGAATGAAGCCAAGAACATTCCAGCCTTTCTACCCAATGTGTTGTCCTTGAAAGAAGCCTTACAAAAGGCTCGAGAATGGACCGCTAAAGTGGAAGCTATTCAGAGTGGCAGCAATTACGCTTATTTGGAGCAGCTTGAGAGCTTGTCTGCGAAAGGACGCCCTATTCCTGTGCGTCTTGAAGCACTGCCGCAAGTGGAATCACAGGTAGCAGCAGCACGGGCATGGAGAGAACGGACTGGGCGGACGTTTCTTAAGAAGAATTCTAGCCATACATTGTTACAGGTGCTGAGCCCCCGGACCGACATTGGTGTATATGGGAGTGGCAAAAATAGGAGGAAAAAAGTAAAAGAACTAATAGAAAAAGAAAAAGAAAAGGATCTGGACCTGGAGCCTCTGAGTGATCTGGAGGAAGGATTGGAGGAAACCAGAGATACAGCCATGGTGGTGGCAGTTTTCAAAGAACGGGAGCAAAAAGAGATTGAAGCCATGCATTCTCTCAGAGCAGCCAACCTAGCCAAGATGACAATGGTGGACCGCATAGAAGAAGTAAAATTTTGCATTTGCCGCAAGACAGCCAGTGGGTTTATGCTACAGTGTGAGCTCTGCAAAGACTGGTTCCATAACAGCTGTGTTCCTCTTCCTAAATCAAGTTCCCAAAAAAAAGGATCCAGCTGGCAAGCTAAAGAAGTAAAATTCCTTTGCCCTCTTTGTATGCGGTCTCGAAGGCCCAGGCTAGAGACTATTCTGTCACTCCTGGTATCCCTTCAGAAGTTGCCCGTACGGTTGCCTGAAGGAGAGGCCCTGCAGTGTTTGACAGAACGTGCTATGAGTTGGCAAGATAGAGCGCGGCAGGCTCTAGCCACAGATGAACTATCCTCTGCCCTGGCCAAACTATCTGTGTTGAGCCAGCGTATGGTGGAACAGGCGGCTCGAGAAAAAACTGAAAAGATCATCAGTGCAGAACTCCAAAAAGCAGCTGCCAATCCAGACTTACAGGGACACTTACCTAGTTTCCAGCAGTCTGCTTTTAACCGGGTGGTGAGCAGTGTGTCATCTTCTCCTCGACAAACAATGGACTATGATGATGAAGAAACAGACTCTGATGAAGACATTCGAGAGACATATGGCTACGACATGAAGGACACAGCCAGTGTGAAGTCCTCTAGTAGTCTTGAACCCAATCTTTTTTGTGATGAAGAGATTCCCATCAAATCCGAGGAGGTGGTGACCCACATGTGGACAGCACCTTCATTTTGTGCAGAGCATGCTTATTCTTCTGCTTCTAAGAGTTGTTCTCAAGGTTCTAGCACCCCAAGGAAACAACCTCGGAAGAGCCCTTTGGTGCCCCGAAGTTTGGAACCTCCAGTGCTGGAGTTGTCACCTGGAGCTAAGGCACAACTGGAAGAACTTATGATGGTTGGAGATCTCCTGGAAGTATCTCTGGACGAGACTCAACACATATGGCGGATTTTGCAGGCCACACACCCACCCTCTGAAGACAGATTCTTGCATATCATGGAGGATGACAGCATGGAAGAGAAACCACTAAAAGTGAAAGGAAAGGACTCTTCAGAGAAGAAACGGAAACGGAAGCTAGAAAAGGTAGAGCAACTTTTTGGAGAAGGAAAACAGAAGTCCAAGGAGTTAAAGAAAATGGACAAACCTAGAAAGAAGAAATTAAAATTAGGTGCAGACAAATCAAAGGAGCTGAATAAACTGGCCAAGAAACTAGCAAAAGAAGAAGAGAGAAAGAAAAAGAAGGAGAAGGCTGCTGCAGCCAAAGTTGAACTTGTGAAAGAGAGCACTGAAAAGAAAAGAGAGAAAAAGGTGCTGGACATCCCCTCAAAGTATGACTGGTCAGGAGCAGAGGAGTCTGATGATGAGAATGCTGTGTGCGCAGCACAGAACTGCCAAAGGCCCTGCAAGGACAAGGTAGACTGGGTACAATGTGATGGTGGCTGTGATGAGTGGTTTCATCAAGTTTGTGTGGGTGTATCTCCAGAAATGGCTGAAAATGAAGATTACATCTGTATAAACTGTGCAAAGAAGCAGGGGCCAGTTAGCCCAGGTCCAGCACCACCTCCTTCCTTCATAATGAGCTACAAACTACCAATGGAGGATCTTAAAGAGACCAGTTAG
ORF Protein Sequence MAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRLDFLDQLAKFWELQGSTLKIPVVERKILDLYALSKIVASKGGFEMVTKEKKWSKVGSRLGYLPGKGTGSLLKSHYERILYPYELFQSGVSLMGVQMPNLDLKEKVEPEVLSTDTQTSPEPGTRMNILPKRTRRVKTQSESGDVSRNTELKKLQIFGAGPKVVGLAMGTKDKEDEVTRRRKVTNRSDAFNMQMRQRKGTLSVNFVDLYVCMFCGRGNNEDKLLLCDGCDDSYHTFCLIPPLPDVPKGDWRCPKCVAEECSKPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCTADWLPIGRQCVNHYRRLRRHCVFSHEELIFKMAADPECLDVGLAAMVCKELTLMTEEETRLRESVVQMGVLMSEEEVFELVPDDERQCSACRTTCFLSALTCSCNPERLVCLYHPTDLCPCPMQKKCLRYRYPLEDLPSLLYGVKVRAQSYDTWVSRVTEALSANFNHKKDLIELRVMLEDAEDRKYPENDLFRKLRDAVKEAETCASVAQLLLSKKQKHRQSPDSGRTRTKLTVEELKAFVQQLFSLPCVISQARQVKNLLDDVEEFHERAQEAMMDETPDSSKLQMLIDMGSSLYVELPELPRLKQELQQARWLDEVRLTLSDPQQVTLDVMKKLIDSGVGLAPHHAVEKAMAELQELLTVSERWEEKAKVCLQARPRHSVASLESIVNEAKNIPAFLPNVLSLKEALQKAREWTAKVEAIQSGSNYAYLEQLESLSAKGRPIPVRLEALPQVESQVAAARAWRERTGRTFLKKNSSHTLLQVLSPRTDIGVYGSGKNRRKKVKELIEKEKEKDLDLEPLSDLEEGLEETRDTAMVVAVFKEREQKEIEAMHSLRAANLAKMTMVDRIEEVKFCICRKTASGFMLQCELCKDWFHNSCVPLPKSSSQKKGSSWQAKEVKFLCPLCMRSRRPRLETILSLLVSLQKLPVRLPEGEALQCLTERAMSWQDRARQALATDELSSALAKLSVLSQRMVEQAAREKTEKIISAELQKAAANPDLQGHLPSFQQSAFNRVVSSVSSSPRQTMDYDDEETDSDEDIRETYGYDMKDTASVKSSSSLEPNLFCDEEIPIKSEEVVTHMWTAPSFCAEHAYSSASKSCSQGSSTPRKQPRKSPLVPRSLEPPVLELSPGAKAQLEELMMVGDLLEVSLDETQHIWRILQATHPPSEDRFLHIMEDDSMEEKPLKVKGKDSSEKKRKRKLEKVEQLFGEGKQKSKELKKMDKPRKKKLKLGADKSKELNKLAKKLAKEEERKKKKEKAAAAKVELVKESTEKKREKKVLDIPSKYDWSGAEESDDENAVCAAQNCQRPCKDKVDWVQCDGGCDEWFHQVCVGVSPEMAENEDYICINCAKKQGPVSPGPAPPPSFIMSYKLPMEDLKETS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T28052-Ab Anti-KDM5A monoclonal antibody
    Target Antigen GM-Tg-g-T28052-Ag KDM5A protein
    ORF Viral Vector pGMAD000038 Human KDM5A Adenovirus plasmid
    ORF Viral Vector vGMAD000038 Human KDM5A Adenovirus particle


    Target information

    Target ID GM-T28052
    Target Name RBP2/KDM5A
    Gene Group Identifier
    （Target Gene ID in Homo species)         		5927
    Gene ID 100056935 (Equus caballus), 101087846 (Felis catus), 214899 (Mus musculus), 312678 (Rattus norvegicus)
    477727 (Canis lupus familiaris), 507962 (Bos taurus), 5927 (Homo sapiens), 721599 (Macaca mulatta)
    Gene Symbols & Synonyms KDM5A,Kdm5a,JARID1A,RBP2,Rbbp2,Jarid1a,RBBP2,NEDEHC,RBBP-2
    Target Alternative Names Histone demethylase JARID1A,JARID1A,Jarid1a,Jumonji/ARID domain-containing protein 1A,KDM5A,Kdm5a,Lysine-specific demethylase 5A,NEDEHC,RBBP-2,RBBP2,RBP2,Rbbp2,Retinoblastoma-binding protein 2 (RBBP-2),[histone H3]-trimethyl-L-lysine(4) demethylase 5A
    Uniprot Accession P29375,Q3UXZ9
    Additional SwissProt Accessions: Q3UXZ9,P29375
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease cancer
    Disease from KEGG
    Gene Ensembl ENSECAG00000021281, ENSMUSG00000030180, ENSCAFG00845027343, ENSBTAG00000020472, ENSG00000073614, ENSMMUG00000013653
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.